Gautam Borthakur, MD
The University of Texas MD Anderson Cancer Centre · M.D. Anderson Cancer Center · MD Anderson Cancer Center Houston, TX 77030
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gautam Borthakur, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:36 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04730258 · A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMMLTreadwell Therapeutics, Inc · active not recruiting · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia · principal investigator
- Ph1NCT04017546 · CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDSCyclacel Pharmaceuticals, Inc. · completed · AML, MDS · principal investigator
- Ph1NCT03884829 · A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDSCyclacel Pharmaceuticals, Inc. · terminated · AML, Adult, Myelodysplastic Syndromes, ALL, Adult · principal investigator
- Ph1/Ph2NCT02418000 · A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras MutationsSpirita Oncology, LLC · terminated · AML, MDS, CMML · study chair
- Ph1/Ph2NCT01828346 · Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine TherapyTetraLogic Pharmaceuticals · completed · Myelodysplastic Syndrome · principal investigator
- Ph1NCT00867230 · FTS Study in Patients With Advanced Hematologic MalignanciesM.D. Anderson Cancer Center · completed · Myelodysplastic Syndrome, Leukemia · principal investigator
- Ph2NCT00360672 · Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic SyndromeM.D. Anderson Cancer Center · completed · Acute Myelogenous Leukemia, Myelodysplastic Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.